Harris D. SGLT2 Inhibitors: A Novel Therapeutic Class for Diabetes Management. CellNatSci [Internet]. 2025 Oct. 20 [cited 2025 Oct. 23];1(1). Available from: https://cnsjournals.com/index.php/cns/article/view/4